Cutera Appoints Stephana Patton as Chief Legal Officer

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Stephana Patton, Ph.D., J.D. as Chief Legal Officer, effective November 13, 2023.

Dr. Patton will report directly to Taylor Harris, Cutera’s Chief Executive Officer, and will be responsible for leading the legal, compliance, intellectual property and human resources functions. Dr. Patton brings over two decades of legal experience, focused on the life sciences industry both in private practice and as in-house counsel, to Cutera.

Taylor Harris, Chief Executive Officer, said, “I am thrilled to welcome Stephana to the Cutera team. Stephana has built a tremendous foundation of experience in the life science industry, including as general counsel for three publicly traded companies, which will serve our company well. In addition, she embodies the core values that our team has committed to as we lead Cutera into the next era.”

Dr. Patton said, “Cutera has a well-established leadership position in the aesthetics industry, and I’m excited to be part of the team that builds upon that legacy, with a focus on operational excellence in all areas, unparalleled support of our customers, and growth of the AviClear franchise.”

About Stephana Patton:

Stephana Patton, Ph.D., J.D. brings over twenty years of legal experience to Cutera. She was most recently Chief Legal Officer at InterVenn Biosciences. Prior to that, she served as General Counsel, Corporate Secretary, and Chief Compliance Officer at Eiger Biopharmaceuticals (NASDAQ:EIGR) where she was responsible for all legal and compliance matters. Previously, Dr. Patton was General Counsel, Corporate Secretary, and Chief Compliance Officer at BioTime, Inc. and Vice President, General Counsel and Commercial Compliance Officer at BioDelivery Sciences International, Inc. Dr. Patton began her life sciences industry career at Salix Pharmaceuticals, Inc., where she was Vice President of Intellectual Property and Licensing, until the company was acquired by Valeant, Inc. in 2015. She earned a B.S. in Chemistry from Erskine College, a Ph.D. in Biochemistry and Cell and Developmental Biology from Emory University, and a J.D. from Boston University School of Law.

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call [phone] or 1-888-4CUTERA or visit www.cutera.com.